Mizuho: Smaller companies are leading the way in developing vaccines for infectious diseases

Mara Goldstein of Mizuho discusses the difficulty of developing a vaccine quickly during a virus outbreak, and which large and smaller biotech and drug companies investors should be focused on.
Fri, Jan 24 20207:05 AM EST